These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 32609979)
21. Resveratrol improves efficacy of oral amoxicillin against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical trial. Qiang L; Di Y; Jiang Z; Xu J Microb Pathog; 2018 Jan; 114():209-212. PubMed ID: 29198820 [TBL] [Abstract][Full Text] [Related]
22. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA; Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775 [TBL] [Abstract][Full Text] [Related]
23. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial. Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM; J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506 [TBL] [Abstract][Full Text] [Related]
24. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial. Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494 [TBL] [Abstract][Full Text] [Related]
25. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia. Bansal A; Singhi SC; Jayashree M Indian J Pediatr; 2006 Apr; 73(4):305-9. PubMed ID: 16816491 [TBL] [Abstract][Full Text] [Related]
26. Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study. Addo-Yobo E; Anh DD; El-Sayed HF; Fox LM; Fox MP; MacLeod W; Saha S; Tuan TA; Thea DM; Qazi S; Trop Med Int Health; 2011 Aug; 16(8):995-1006. PubMed ID: 21545381 [TBL] [Abstract][Full Text] [Related]
27. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial. Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325 [TBL] [Abstract][Full Text] [Related]
28. Effect of enhancing audit and feedback on uptake of childhood pneumonia treatment policy in hospitals that are part of a clinical network: a cluster randomized trial. Ayieko P; Irimu G; Ogero M; Mwaniki P; Malla L; Julius T; Chepkirui M; Mbevi G; Oliwa J; Agweyu A; Akech S; Were F; English M; Implement Sci; 2019 Mar; 14(1):20. PubMed ID: 30832678 [TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918 [TBL] [Abstract][Full Text] [Related]
30. Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial. Agweyu A; Gathara D; Oliwa J; Muinga N; Edwards T; Allen E; Maleche-Obimbo E; English M; Clin Infect Dis; 2015 Apr; 60(8):1216-24. PubMed ID: 25550349 [TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study "Innovative Treatments in Pneumonia". Ginsburg AS; May S; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N JMIR Res Protoc; 2019 Jul; 8(7):e13377. PubMed ID: 31359870 [TBL] [Abstract][Full Text] [Related]
32. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830 [TBL] [Abstract][Full Text] [Related]
33. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Little P; Francis NA; Stuart B; O'Reilly G; Thompson N; Becque T; Hay AD; Wang K; Sharland M; Harnden A; Yao G; Raftery J; Zhu S; Little J; Hookham C; Rowley K; Euden J; Harman K; Coenen S; Read RC; Woods C; Butler CC; Faust SN; Leydon G; Wan M; Hood K; Whitehurst J; Richards-Hall S; Smith P; Thomas M; Moore M; Verheij T Lancet; 2021 Oct; 398(10309):1417-1426. PubMed ID: 34562391 [TBL] [Abstract][Full Text] [Related]
34. Treatment with amoxicillin for 3 days for chest-indrawing pneumonia was non-inferior to treatment for 5 days in HIV-uninfected Malawian children. Ntovolou AA; Murphy S Arch Dis Child Educ Pract Ed; 2022 Aug; 107(4):309. PubMed ID: 33355209 [No Abstract] [Full Text] [Related]
35. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan. Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055 [TBL] [Abstract][Full Text] [Related]
37. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082 [TBL] [Abstract][Full Text] [Related]
38. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT). Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M; BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008 [TBL] [Abstract][Full Text] [Related]
39. One-arm safety intervention study on community case management of chest indrawing pneumonia in children in Nigeria - a study protocol. Counihan H; Baba E; Oresanya O; Adesoro O; Hamzat Y; Marks S; Ward C; Gimba P; Qazi SA; Källander K Glob Health Action; 2020 Dec; 13(1):1775368. PubMed ID: 32856569 [TBL] [Abstract][Full Text] [Related]
40. Repeat assessment of physical examination findings among HIV-uninfected children in Malawi with chest-indrawing pneumonia: Recto: Chest-indrawing pneumonia in HIV-uninfected. Ginsburg AS; Mvalo T; May S Int J Infect Dis; 2021 Sep; 110():371-373. PubMed ID: 34343705 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]